MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

Among childhood cancers, neuroblastoma is the most diffuse solid tumor and the deadliest in children. While to date, the pathology has become progressively manageable with a significant increase in 5-year survival for its less aggressive form, high-risk neuroblastoma (HR-NB) remains a major issue wi...

Full description

Bibliographic Details
Main Authors: Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, Silvia Lampis, Andrea Pession, Patrizia Hrelia, Roberto Tonelli
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
MYCN
high-risk neuroblastoma
pediatric tumor
neuroblastoma therapeutics
undruggable targets
Online Access:https://www.mdpi.com/2072-6694/14/18/4421

Internet

https://www.mdpi.com/2072-6694/14/18/4421

Similar Items